Logo image of KVHI

KVH INDUSTRIES INC (KVHI) Stock Fundamental Analysis

NASDAQ:KVHI - Nasdaq - US4827381017 - Common Stock - Currency: USD

5.28  -0.05 (-0.94%)

Fundamental Rating

4

Taking everything into account, KVHI scores 4 out of 10 in our fundamental rating. KVHI was compared to 48 industry peers in the Communications Equipment industry. KVHI has a great financial health rating, but its profitability evaluates not so good. KVHI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year KVHI has reported negative net income.
KVHI had a negative operating cash flow in the past year.
KVHI had negative earnings in 4 of the past 5 years.
In multiple years KVHI reported negative operating cash flow during the last 5 years.
KVHI Yearly Net Income VS EBIT VS OCF VS FCFKVHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

KVHI has a worse Return On Assets (-6.34%) than 60.42% of its industry peers.
KVHI has a Return On Equity (-6.96%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.34%
ROE -6.96%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-4.35%
ROE(3y)-1.02%
ROE(5y)-5.45%
ROIC(3y)N/A
ROIC(5y)N/A
KVHI Yearly ROA, ROE, ROICKVHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With a Gross Margin value of 29.77%, KVHI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
KVHI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for KVHI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-2.92%
KVHI Yearly Profit, Operating, Gross MarginsKVHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

8

2. Health

2.1 Basic Checks

KVHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KVHI has been increased compared to 1 year ago.
KVHI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for KVHI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KVHI Yearly Shares OutstandingKVHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
KVHI Yearly Total Debt VS Total AssetsKVHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 5.81 indicates that KVHI is not in any danger for bankruptcy at the moment.
The Altman-Z score of KVHI (5.81) is better than 85.42% of its industry peers.
KVHI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.81
ROIC/WACCN/A
WACC9.19%
KVHI Yearly LT Debt VS Equity VS FCFKVHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 9.31 indicates that KVHI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 9.31, KVHI belongs to the top of the industry, outperforming 97.92% of the companies in the same industry.
KVHI has a Quick Ratio of 7.63. This indicates that KVHI is financially healthy and has no problem in meeting its short term obligations.
KVHI has a Quick ratio of 7.63. This is amongst the best in the industry. KVHI outperforms 97.92% of its industry peers.
Industry RankSector Rank
Current Ratio 9.31
Quick Ratio 7.63
KVHI Yearly Current Assets VS Current LiabilitesKVHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

KVHI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.91%, which is quite impressive.
The Revenue for KVHI has decreased by -14.01% in the past year. This is quite bad
Measured over the past years, KVHI shows a decrease in Revenue. The Revenue has been decreasing by -6.34% on average per year.
EPS 1Y (TTM)69.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)-14.01%
Revenue growth 3Y-5.27%
Revenue growth 5Y-6.34%
Sales Q2Q%-7.16%

3.2 Future

Based on estimates for the next years, KVHI will show a very strong growth in Earnings Per Share. The EPS will grow by 45.23% on average per year.
Based on estimates for the next years, KVHI will show a small growth in Revenue. The Revenue will grow by 5.11% on average per year.
EPS Next Y76.32%
EPS Next 2Y45.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.9%
Revenue Next 2Y5.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KVHI Yearly Revenue VS EstimatesKVHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
KVHI Yearly EPS VS EstimatesKVHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KVHI. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 86.27, which means the current valuation is very expensive for KVHI.
Based on the Price/Forward Earnings ratio, KVHI is valued a bit more expensive than 62.50% of the companies in the same industry.
KVHI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE N/A
Fwd PE 86.27
KVHI Price Earnings VS Forward Price EarningsKVHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KVHI indicates a somewhat cheap valuation: KVHI is cheaper than 68.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.64
KVHI Per share dataKVHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

KVHI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
KVHI's earnings are expected to grow with 45.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KVHI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KVH INDUSTRIES INC

NASDAQ:KVHI (8/8/2025, 8:00:02 PM)

5.28

-0.05 (-0.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners41.17%
Inst Owner Change-4.29%
Ins Owners16.89%
Ins Owner Change-0.34%
Market Cap103.49M
Analysts82.86
Price TargetN/A
Short Float %0.4%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-279.9%
Min EPS beat(2)-439.22%
Max EPS beat(2)-120.59%
EPS beat(4)0
Avg EPS beat(4)-152.04%
Min EPS beat(4)-439.22%
Max EPS beat(4)-17.65%
EPS beat(8)2
Avg EPS beat(8)-437.16%
EPS beat(12)5
Avg EPS beat(12)-223.08%
EPS beat(16)8
Avg EPS beat(16)-163.12%
Revenue beat(2)0
Avg Revenue beat(2)-9.01%
Min Revenue beat(2)-12.24%
Max Revenue beat(2)-5.79%
Revenue beat(4)1
Avg Revenue beat(4)-5.99%
Min Revenue beat(4)-12.24%
Max Revenue beat(4)0.36%
Revenue beat(8)1
Avg Revenue beat(8)-6.7%
Revenue beat(12)2
Avg Revenue beat(12)-7.39%
Revenue beat(16)3
Avg Revenue beat(16)-9.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)40%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 86.27
P/S 0.94
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA 14.64
EPS(TTM)-0.34
EYN/A
EPS(NY)0.06
Fwd EY1.16%
FCF(TTM)-1.02
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS5.61
BVpS7.03
TBVpS6.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -6.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.77%
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-4.35%
ROE(3y)-1.02%
ROE(5y)-5.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-2.92%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 48.49%
Cap/Sales 5.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.31
Quick Ratio 7.63
Altman-Z 5.81
F-Score5
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)82.67%
Cap/Depr(5y)99.61%
Cap/Sales(3y)8.66%
Cap/Sales(5y)9.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y76.32%
EPS Next 2Y45.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.01%
Revenue growth 3Y-5.27%
Revenue growth 5Y-6.34%
Sales Q2Q%-7.16%
Revenue Next Year-1.9%
Revenue Next 2Y5.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year191.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-204.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-342.97%
OCF growth 3YN/A
OCF growth 5YN/A